Click here to create your personal news page. The news that appears on abiraterone will appear there and be constantly updated. You can then modify the page, share it with your friends, or export it and have it appear elsewhere.

You can also create a personal news page and follow the news that interests you by clicking on the tab labelled 'New page'.  

topics : related - allExplore

Shopping Categories

  1. 1. Mobile Phone
  2. 2. Smartphone
  3. 3. Digital Camera
  4. 4. Laptop Computer
  5. 5. LCD Monitor
  6. 6. Printer
  7. 7. Graphic Card
  8. 8. GPS
  9. 9. Motherboard
  10. 10. Digital Camcorder
  11. 11. Processor
  12. 12. Desktop Computer
  13. 13. A/V Amplifier
  14. 14. Fan & Accessories
  15. 15. Sound Card

Wikio Shopping

  1. 1. Automotive
  2. 2. Beauty & Fragrances
  3. 3. Car/Motor Bike
  4. 4. Clothing, Accessories & Shoes
  5. 5. Communication
  6. 6. Computers
  7. 7. Electronics
  8. 8. Flowers & Gifts
  9. 9. Gourmet & Foods
  10. 10. Health & Personal Care
  11. 11. Home & Garden
  12. 12. Household Appliances
  13. 13. Jewelry & Watches
  14. 14. Musical Instruments
  15. 15. Sports & Outdoors
  16. 16. Toys & Baby
  17. 17. Video Games

Participate

News Categories



abiraterone



Sort by : relevance - date
+Vote!

Interim Phase II Results Support Efficacy Of CB7630 (Abiraterone Acetate) In Advanced Prostate Cancer Patients

Medical News Today (Free subscription) | 10/21/2008

Cougar Biotechnology, Inc. (NASDAQ:CGRB) today announced that results from an ongoing Phase II clinical trial of Cougar's investigational drug CB7630 (abiraterone acetate) were presented today at the Prostate Cancer Foundation Scientific Retreat. The Prostate Cancer Foundation Scientific Retreat is currently taking place in Lake Tahoe, Nevada.

+Vote!

Cougar Biotechnology Announces Initiation of Phase I/II Trial of CB7630 (Abiraterone Acetate) in Advanced Breast Cancer Patients

Business Wire (Free subscription) | 11/20/2008

LOS ANGELES--(BUSINESS WIRE)--Cougar Biotechnology, Inc. (NASDAQ: CGRB) today announced that the first patient was enrolled in a Phase I/II clinical trial of the Company’s drug candidate CB7630 (abiraterone

+Vote!

Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse Drugs Approaching the Market for Many Tumor Types

Business Wire (Free subscription) | 10/28/2008

... favorable backing of Genentech and Roche, who have considerable experience in the oncology market. Abiraterone (CB-7630; Cougar Biotechnology/BTG) shows the greatest potential in the prostate cancer pipeline. Abiraterone shows real promise in providing an effective therapy in the second-line or higher setting among patients where all lines of antihormonal therapy and Taxotere (docetaxel;...

+Vote!

Cougar Biotechnology Presents Positive CB7630 Phase II Data at EORTC-NCI-AACR Symposium

Business Wire (Free subscription) | 10/23/2008

Cougar Biotechnology Presents Positive CB7630 Phase II Data at EORTC-NCI-AACR SymposiumInterim Phase II Results Support Efficacy of CB7630 (Abiraterone Acetate) in Chemotherapy Naïve, Ketoconazole Naïve Advanced Prostate Cancer PatientsLOS ANGELES--()--Cougar Biotechnology, Inc. (NASDAQ:CGRB) today announced that results from an ongoing Phase II clinical trial of Cougars investigational drug...